C Fleissner Selected Research

Metallothionein

9/2001

Intrinsic expression of drug resistance-associated factors in meningiomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Fleissner Research Topics

Disease

4	Multiple Myeloma 01/2009 - 01/2007
3	Neoplasms (Cancer) 01/2009 - 09/2001
2	Bone Resorption 09/2008 - 09/2007
1	Acute Kidney Injury (Acute Renal Failure) 01/2009
1	Bone Diseases (Bone Disease) 09/2008
1	Inflammation (Inflammations) 01/2007
1	Ischemia 01/2007
1	Reperfusion Injury 01/2007
1	Stroke (Strokes) 01/2007
1	Meningioma (Meningiomas) 09/2001

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2009 - 09/2001
2	NF-kappa B (NF-kB)IBA 09/2007 - 01/2007
2	Bortezomib (Velcade)FDA Link 09/2007 - 01/2007
1	AlbuminsIBA 09/2008
1	Biomarkers (Surrogate Marker)IBA 09/2008
1	CollagenIBA 09/2008
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2007
1	PS1145IBA 09/2007
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 09/2007
1	LigandsIBA 09/2007
1	PS519IBA 01/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2001
1	Pharmaceutical PreparationsIBA 09/2001
1	Multidrug Resistance-Associated ProteinsIBA 09/2001
1	MetallothioneinIBA 09/2001

Therapy/Procedure

1	Therapeutics 09/2008
1	Drug Therapy (Chemotherapy) 09/2001
1	Adjuvant Chemotherapy 09/2001